Begin main content

Reports

We found 5813 result(s)

dupilumab (Dupixent)

Last Updated: November 14, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: dupilumab
Indications: atopic dermatitis

  • Brand Name: Dupixent
  • Manufacturer: Sanofi Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0636-000
  • Project Status: Active
  • Submission Type: New

ustekinumab (Stelara/Stelara I.V)

Last Updated: November 14, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: ustekinumab
Indications: Ulcerative colitis

  • Brand Name: Stelara/Stelara I.V
  • Manufacturer: Janssen Inc.
  • Project Number: SR0627-000
  • Project Status: Active
  • Submission Type: New Indication

An Overview of Liquid Biopsy for Screening and Early Detection of Cancer

Last Updated: November 14, 2019
Result type: Reports
opens in document viewer

Methods CADTH Horizon Scanning bulletins present an overview of the technology and available evidence. They are not systematic reviews and do not involve critical appraisal, nor do they include a detailed summary of study findings. Therefore, they are not intended to provide recommendations for or against a particular technology. Literature Se...

  • Project Number: EH0077-000

teduglutide (Revestive)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: teduglutide
Indications: Short Bowel Syndrome (SBS), pediatrics

  • Brand Name: Revestive
  • Manufacturer: Shire Pharmaceuticals Ireland Limited
  • Project Number: SR0606-000
  • Project Status: Active
  • Submission Type: New Indication

lanadelumab (Takhzyro)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: lanadelumab
Indications: Hereditary angioedema, prevention

  • Brand Name: Takhzyro
  • Manufacturer: Shire Pharma Canada ULC
  • Project Number: SR0618-000
  • Project Status: Active
  • Submission Type: New

tildrakizumab (Ilumya )

Last Updated: November 11, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: tildrakizumab
Indications: Psoriasis, moderate to severe plaque

  • Brand Name: Ilumya
  • Manufacturer: Sun Pharma Canada
  • Project Number: SR0624-000
  • Project Status: Active
  • Submission Type: New

cyclosporine (Verkazia)

Last Updated: November 12, 2019
Result type: Reports
Product Line: Common Drug Review
Generic Name: cyclosporine
Indications: Severe vernal keratoconjunctivitis, pediatric (≥4 years)

  • Brand Name: Verkazia
  • Manufacturer: Santen Inc.
  • Project Number: SR0615-000
  • Project Status: Active
  • Submission Type: New